
1118567-05-7 Bexagliflozin
CAS:1118567-05-7
MF:C24H29ClO7
MW:464.94
EINECS:257-874-6
MDL No.:MFCD28100944
Properties
Appearance crystalline solid
Boiling point:671.0±55.0 °C
Density 1.41
storage temp. Store at -20°C
solubility DMSO:100.0(Max Conc. mg/mL);215.08(Max Conc. mM)
pka13.23±0.70
Application:
Bexagliflozin is a SGLT2 inhibitor, which is mainly used to improve the blood sugar control of adult type 2 diabetes patients. It can reduce blood sugar, weight and blood pressure by inhibiting SGLT2 of renal tubular epithelial cells, increasing body heat consumption, reducing fluid retention, and increasing urine glucose excretion. Bexagliflozin has a clear protective effect on cardiovascular and renal health, and has performed well in clinical trials with significant efficacy and high safety
| Detailed Applications |
✅ Pharmaceutical API 1. Adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus (T2DM), effectively reduces HbA1c levels and fasting blood glucose. 2. The first FDA-approved SGLT2 inhibitor for feline diabetes mellitus (2022), with significant blood glucose-lowering effect on diabetic cats. 3. Applicable for T2DM patients with moderate renal impairment (eGFR ≥30 mL/min/1.73m²), safe for renal insufficiency population.
✅ Formulation Development 1. Commercial dosage form: 20 mg oral tablets (brand name: Brenzavvy), blue capsule-shaped film-coated tablets, non-chewable. 2. R&D dosage forms: oral suspension, sustained-release tablets, for pediatric/geriatric T2DM patients with swallowing difficulties.
✅ Biomedical Research1. Research on SGLT2 inhibitor's anti-diabetic mechanism, renal glucose transport pathway.2. Preclinical study on potential efficacy for heart failure, diabetic nephropathy and obesity. |
| Packaging Specifications |
▶ API Raw Material Packaging (GMP Standard)▸ Lab/Research Grade: Sealed amber glass vials with Teflon-lined caps, specs: 1g, 5g, 10g, 25g, 50g, 100g; purity ≥99.5%, vacuum-sealed to prevent moisture/oxidation. ▸ Industrial/Pharmaceutical Grade: HDPE plastic drums/fiber drums with double PE inner liners, specs: 1kg, 5kg, 25kg, 50kg; drum labels include CAS No., batch, purity, net weight, storage conditions and GMP certification. ▸ Customized Packaging: 10g/50g/100g aluminum foil bags for small-batch export/research use.
▶ Finished Product Packaging (20mg Tablets)▸ HDPE bottles with child-resistant caps, specs: 30 tablets/bottle, 90 tablets/bottle; film-coated blister packs optional.
▶ Storage & Shelf Life Requirements 1. API storage: 2-8°C cold storage, protected from light, dry and ventilated environment; shelf life 24 months under sealed condition. 2. Finished tablets: 20-25°C (allow 15-30°C temporary storage), avoid high humidity; shelf life 36 months. 3. Transportation: Cold chain for small-batch API; normal temperature for finished products with moisture-proof packaging. |
Synthetic Route:
| Synthetic Route (Scalable Process) |
Raw Material: (5-bromo-2-chlorophenyl)(4-(2-cyclopropyloxyethoxy)phenyl)methane Steps (7-step scalable synthesis, yield ≥70%, purity >99.5%): 1. Grignard Exchange Reaction: Replace n-butyllithium with iPrMgCl-LiCl complex (mild condition, -15~-30°C), react with raw material to form aryl magnesium bromide intermediate (avoid ultra-low temperature -70~-80°C). 2. Nucleophilic Addition: React the intermediate with protected D-gluconolactone (TMS protection) to form a sugar ring adduct; solvent: THF/toluene mixture. 3. Deprotection: Hydrolyze with dilute acetic acid (7.5% aqueous solution) to remove trimethylsilyl (TMS) protective group, obtain diol intermediate. 4. Methylation: Methylate the hydroxyl group with methyl iodide under alkaline condition, form methoxy intermediate. 5. Demethylation Reduction: Remove methoxy group via catalytic hydrogenation (Pd/C catalyst), generate trihydroxy sugar ring structure. 6. Salt Formation & Purification: Form diproline solvate for purification, remove impurities by recrystallization (solvent: ethanol/water). 7. Free Base & Crystallization: Adjust pH to neutral with weak base, crystallize to obtain pure Bexagliflozin white powder.
Advantage: Avoid expensive iodine raw material/n-butyllithium, mild reaction condition, high atom utilization, suitable for industrial mass production. |
Synonyms:
Bexagliflozin
1118567-05-7
EGT1442
BRENZAVVY
EGT-1442
THR-1442
bexagliflozina
THR1442
bexagliflozinum
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(2-cyclopropoxyethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-(2-(cyclopropyloxy)ethoxy)phenyl)methyl)phenyl)-, (1S)-
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]phenyl]-D-glucitol
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-((4-(2-(cyclopropyloxy)ethoxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Bexacat
Brenzavvy
(2S,3R,4R,5S,6R)-2-[4-Chloro-3-({4-[2-(cyclopropyloxy)ethoxy]phenyl}methyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]phenyl]-, (1S)-
bexagliflozin tablets
EGT1442; Bexagliflozin
BEXAGLIFLOZIN
Hot Tags: 1118567-05-7 bexagliflozin, China 1118567-05-7 bexagliflozin manufacturers, suppliers, api large enterprise api integration, api service oriented architecture, api sales force automation api integration, Glycocholic acid, api availability, api payment gateway integration

